Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy AdultsNot Yet Recruiting
Sponsor: Pfizer
Healthy
Sponsor: Pfizer
Sickle Cell Disease
United States, Nigeria
- Nasopharyngeal Carriage of S. PneumoniaeRecruiting
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne
Nasopharyngeal Carriage · Children, Only · Antibiotic Resistant Strain
France
- A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Active Not Recruiting
Sponsor: Pfizer
Atopic Dermatitis
Japan
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne
Infection Due to Resistant Bacteria · Multi-antibiotic Resistance · Antibiotic Prescription · Risk Factors
France
- Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast CancerActive Not Recruiting
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Breast Cancer
United States
Sponsor: Pfizer
Heart Failure
United States, Australia, Canada, China, Czechia +6 more
Sponsor: Pfizer
Acute Treatment of Migraine
United States
- A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerActive Not Recruiting
Sponsor: Pfizer
Advanced Breast Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Pfizer
Malignant Melanoma · Melanoma · Metastatic Melanoma · Solid Tumors
United States, France, Spain, Sweden, United Kingdom
Sponsor: ZHOU FANGJIAN
Renal Cell Carcinoma · Neoadjuvant
China
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaActive Not Recruiting
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Ciliary Body and Choroid Melanoma, Medium/Large Size · Ciliary Body and Choroid Melanoma, Small Size · Iris Melanoma · Stage I Intraocular Melanoma
United States
- Elranatamab in R/R Multiple MyelomaRecruiting
Sponsor: Massachusetts General Hospital
Refractory Multiple Myeloma · Relapse Multiple Myeloma · Multiple Myeloma
United States
- Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)Active Not Recruiting
Sponsor: Pfizer
Metastatic HER2+ Advanced Breast Cancer · Breast Neoplasms · Gastric or Gastroesophageal Junction Adenocarcinoma (GEC) · Colorectal Cancer
China
- A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and InfantActive Not Recruiting
Sponsor: Pfizer
Pneumococcal Disease
China
- A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six MonthsActive Not Recruiting
Sponsor: Pfizer
Pneumococcal Disease
Japan
- ELISA in Relapsed/Refractory MMRecruiting
Sponsor: Massachusetts General Hospital
Relapsed Refractory Multiple Myeloma (RRMM) · Relapsed Refractory Multiple Myeloma
United States
Sponsor: Pfizer
Pneumococcal Immunization · Safety
South Korea
Sponsor: Pfizer
Pneumococcal Disease
United States, Puerto Rico
Sponsor: Pfizer
Healthy Participants
Netherlands
Sponsor: Pfizer
Sickle Cell Disease
United States, Egypt, Ghana, Italy, Kenya +4 more
Sponsor: UNC Lineberger Comprehensive Cancer Center
Cancer of the Colon · Colon Cancer · Colon Neoplasms · Colonic Cancer
United States
Sponsor: Pfizer
Non-Small Cell Lung Carcinoma
Taiwan
Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
Celiac Disease
United States, Australia, New Zealand
Sponsor: Ohio State University Comprehensive Cancer Center
Prostate Adenocarcinoma · Stage IIB Prostate Cancer AJCC v8 · Stage IIC Prostate Cancer AJCC v8
United States